Skip to main content

Concordia’s Photodynamic Therapy Laser Receives Premarket Approval

Concordia International Corp. said that the U.S. Food and Drug Administration has approved the Company’s premarket approval application for its Photofrin 630 PDT (photodynamic therapy) Laser.
http://www.photonics.com/Article.aspx?AID=60901

AUDIENCES

SUBJECTS

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino